The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pompe Disease Treatment-Global Market Insights and Sales Trends 2025
Synopsis
Pompe disease is a rare disease, also known as acid maltase deficiency (AMD) or glycogen storage disorder (GSD).Glycogenosis II is also called "glycogenosis type 2".
The global Pompe Disease Treatment market size is expected to reach US$ 1093.5 million by 2029, growing at a CAGR of 2.1% from 2023 to 2029. The market is mainly driven by the significant applications of Pompe Disease Treatment in various end use industries. The expanding demands from the Hospital, Medical Center and Other, are propelling Pompe Disease Treatment market. Infantile-Onset Pompe Disease, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adult-Onset Pompe Disease segment is estimated at % CAGR for the next seven-year period.
The availability of reimbursement policies for the treatment Pompe disease as one of the primary factors that will have a positive impact on the growth of this market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pompe Disease Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pompe Disease Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pompe Disease Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pompe Disease Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pompe Disease Treatment covered in this report include Amicus Therapeutics, Audentes Therapeutics, Sanofi Genzyme, EpiVax, Oxyrane, Sangamo BioSciences and Valerion Therapeutics, etc.
The global Pompe Disease Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amicus Therapeutics
Audentes Therapeutics
Sanofi Genzyme
EpiVax
Oxyrane
Sangamo BioSciences
Valerion Therapeutics
Global Pompe Disease Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pompe Disease Treatment market, Segment by Type:
Infantile-Onset Pompe Disease
Adult-Onset Pompe Disease
Global Pompe Disease Treatment market, by Application
Hospital
Medical Center
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pompe Disease Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Pompe disease is a rare disease, also known as acid maltase deficiency (AMD) or glycogen storage disorder (GSD).Glycogenosis II is also called "glycogenosis type 2".
The global Pompe Disease Treatment market size is expected to reach US$ 1093.5 million by 2029, growing at a CAGR of 2.1% from 2023 to 2029. The market is mainly driven by the significant applications of Pompe Disease Treatment in various end use industries. The expanding demands from the Hospital, Medical Center and Other, are propelling Pompe Disease Treatment market. Infantile-Onset Pompe Disease, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adult-Onset Pompe Disease segment is estimated at % CAGR for the next seven-year period.
The availability of reimbursement policies for the treatment Pompe disease as one of the primary factors that will have a positive impact on the growth of this market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pompe Disease Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pompe Disease Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pompe Disease Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pompe Disease Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pompe Disease Treatment covered in this report include Amicus Therapeutics, Audentes Therapeutics, Sanofi Genzyme, EpiVax, Oxyrane, Sangamo BioSciences and Valerion Therapeutics, etc.
The global Pompe Disease Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amicus Therapeutics
Audentes Therapeutics
Sanofi Genzyme
EpiVax
Oxyrane
Sangamo BioSciences
Valerion Therapeutics
Global Pompe Disease Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pompe Disease Treatment market, Segment by Type:
Infantile-Onset Pompe Disease
Adult-Onset Pompe Disease
Global Pompe Disease Treatment market, by Application
Hospital
Medical Center
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pompe Disease Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pompe Disease Treatment
1.1 Pompe Disease Treatment Market Overview
1.1.1 Pompe Disease Treatment Product Scope
1.1.2 Pompe Disease Treatment Market Status and Outlook
1.2 Global Pompe Disease Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pompe Disease Treatment Market Size by Region (2018-2029)
1.4 Global Pompe Disease Treatment Historic Market Size by Region (2018-2023)
1.5 Global Pompe Disease Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pompe Disease Treatment Market Size (2018-2029)
1.6.1 North America Pompe Disease Treatment Market Size (2018-2029)
1.6.2 Europe Pompe Disease Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Pompe Disease Treatment Market Size (2018-2029)
1.6.4 Latin America Pompe Disease Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Pompe Disease Treatment Market Size (2018-2029)
2 Pompe Disease Treatment Market by Type
2.1 Introduction
2.1.1 Infantile-Onset Pompe Disease
2.1.2 Adult-Onset Pompe Disease
2.2 Global Pompe Disease Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pompe Disease Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Pompe Disease Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pompe Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pompe Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pompe Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pompe Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pompe Disease Treatment Revenue Breakdown by Type (2018-2029)
3 Pompe Disease Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Medical Center
3.1.3 Other
3.2 Global Pompe Disease Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pompe Disease Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Pompe Disease Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pompe Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pompe Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pompe Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pompe Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pompe Disease Treatment Revenue Breakdown by Application (2018-2029)
4 Pompe Disease Treatment Competition Analysis by Players
4.1 Global Pompe Disease Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pompe Disease Treatment as of 2022)
4.3 Date of Key Players Enter into Pompe Disease Treatment Market
4.4 Global Top Players Pompe Disease Treatment Headquarters and Area Served
4.5 Key Players Pompe Disease Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Pompe Disease Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Amicus Therapeutics
5.1.1 Amicus Therapeutics Profile
5.1.2 Amicus Therapeutics Main Business
5.1.3 Amicus Therapeutics Pompe Disease Treatment Products, Services and Solutions
5.1.4 Amicus Therapeutics Pompe Disease Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Amicus Therapeutics Recent Developments
5.2 Audentes Therapeutics
5.2.1 Audentes Therapeutics Profile
5.2.2 Audentes Therapeutics Main Business
5.2.3 Audentes Therapeutics Pompe Disease Treatment Products, Services and Solutions
5.2.4 Audentes Therapeutics Pompe Disease Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Audentes Therapeutics Recent Developments
5.3 Sanofi Genzyme
5.3.1 Sanofi Genzyme Profile
5.3.2 Sanofi Genzyme Main Business
5.3.3 Sanofi Genzyme Pompe Disease Treatment Products, Services and Solutions
5.3.4 Sanofi Genzyme Pompe Disease Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 EpiVax Recent Developments
5.4 EpiVax
5.4.1 EpiVax Profile
5.4.2 EpiVax Main Business
5.4.3 EpiVax Pompe Disease Treatment Products, Services and Solutions
5.4.4 EpiVax Pompe Disease Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 EpiVax Recent Developments
5.5 Oxyrane
5.5.1 Oxyrane Profile
5.5.2 Oxyrane Main Business
5.5.3 Oxyrane Pompe Disease Treatment Products, Services and Solutions
5.5.4 Oxyrane Pompe Disease Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Oxyrane Recent Developments
5.6 Sangamo BioSciences
5.6.1 Sangamo BioSciences Profile
5.6.2 Sangamo BioSciences Main Business
5.6.3 Sangamo BioSciences Pompe Disease Treatment Products, Services and Solutions
5.6.4 Sangamo BioSciences Pompe Disease Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Sangamo BioSciences Recent Developments
5.7 Valerion Therapeutics
5.7.1 Valerion Therapeutics Profile
5.7.2 Valerion Therapeutics Main Business
5.7.3 Valerion Therapeutics Pompe Disease Treatment Products, Services and Solutions
5.7.4 Valerion Therapeutics Pompe Disease Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Valerion Therapeutics Recent Developments
6 North America
6.1 North America Pompe Disease Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pompe Disease Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pompe Disease Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pompe Disease Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pompe Disease Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pompe Disease Treatment Market Dynamics
11.1 Pompe Disease Treatment Industry Trends
11.2 Pompe Disease Treatment Market Drivers
11.3 Pompe Disease Treatment Market Challenges
11.4 Pompe Disease Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
